A serological assay to detect SARS-CoV-2 seroconversion in humans

SARS-Cov-2 (severe acute respiratory disease coronavirus 2), which causes Coronavirus Disease 2019 (COVID19) was first detected in China in late 2019 and has since then caused a global pandemic. While molecular assays to directly detect the viral genetic material are available for the diagnosis of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Amanat, Fatima, Stadlbauer, Daniel, Strohmeier, Shirin, Nguyen, Thi H.O., Chromikova, Veronika, McMahon, Meagan, Jiang, Kaijun, Asthagiri Arunkumar, Guha, Jurczyszak, Denise, Polanco, Jose, Bermudez-Gonzalez, Maria, Kleiner, Giulio, Aydillo, Teresa, Miorin, Lisa, Fierer, Daniel, Amarilis Lugo, Luz, Milunka Kojic, Erna, Stoever, Jonathan, Liu, Sean T. H., Cunningham-Rundles, Charlotte, Felgner, Philip L., Moran, Thomas, Garcia-Sastre, Adolfo, Caplivski, Daniel, Cheng, Allen, Kedzierska, Katherine, Vapalahti, Olli, Hepojoki, Jussi M., Simon, Viviana, Krammer, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239062/
https://www.ncbi.nlm.nih.gov/pubmed/32511441
http://dx.doi.org/10.1101/2020.03.17.20037713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239062/
https://www.ncbi.nlm.nih.gov/pubmed/32511441
http://dx.doi.org/10.1101/2020.03.17.20037713

Ejemplares similares